Filing Details
- Accession Number:
- 0001209191-13-014251
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-05 18:17:05
- Reporting Period:
- 2013-03-01
- Filing Date:
- 2013-03-05
- Accepted Time:
- 2013-03-05 18:17:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1254419 | Medassets Inc | MDAS | Services-Prepackaged Software (7372) | 510391128 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522395 | A Gregory Strobel | 100 North Point Center East Suite 200 Alpharetta GA 30022 | President, Revenue Cycle Mgmt | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-01 | 6,064 | $0.00 | 6,064 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-01 | 6,064 | $18.82 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-05 | 7,222 | $0.00 | 7,222 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-05 | 7,222 | $19.01 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-03-01 | 3,618 | $0.00 | 3,618 | $15.95 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2013-03-01 | 11,933 | $0.00 | 11,933 | $14.74 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2013-03-01 | 21,998 | $0.00 | 21,998 | $15.57 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2013-03-05 | 53,000 | $0.00 | 53,000 | $15.57 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2013-03-01 | 6,000 | $0.00 | 6,000 | $11.58 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2013-03-05 | 2,000 | $0.00 | 2,000 | $11.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-03-25 | No | 4 | M | Direct | |
| 0 | 2016-01-05 | No | 4 | M | Direct | |
| 158,002 | 2018-03-03 | No | 4 | M | Direct | |
| 105,002 | 2018-03-03 | No | 4 | M | Direct | |
| 88,002 | 2018-11-09 | No | 4 | M | Direct | |
| 86,002 | 2018-11-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Restricted Stock | 7,914 | Direct | |
| Restricted Stock | 11,871 | Direct | |
| Restricted Stock | 11,871 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $22.45 | 2009-11-12 | 50,000 | 50,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2009-11-12 | 50,000 | 50,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $18.85, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.99 to $19.08, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
- The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
- The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
- The reporting person was granted these stock options on March 25, 2008 and are fully vested.
- The reporting person was granted these SSARs on January 5, 2009 and are fully vested.
- The reporting person was granted these stock-settled stock appreciation rights (SSARs) on March 3, 2011. The SSARS vest equally (over the course of 60 months) beginning on March 1, 2011 such that 100% of the SSARs will be fully vested on February 1, 2016.
- The reporting person was granted these SSARs on November 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2011 such that 100% of the SSARs will be fully vested on October 1, 2016.
- The reporting person was granted these stock options on November 12, 2009. The stock options vest equally (over the course of 60 months) on the first day of each month beginning on November 1, 2009, such that 100% of the options will be fully vested on October 1, 2014.
Billionaire Hedge Funds
